IndraLab

Statements

Oligonucleotide inhibits TLR7. 1 / 1

| 1

reach

"Their leader, IMO-8400 (also known as Bazlitoran, sequence: CTATCTNNNNTTCTCTNN), is an oligonucleotide antagonist of TLR7, TLR8 and TLR9, currently in clinical development (phase IIa) for the treatment of plaque psoriasis (NCT01899729) and dermatomyositis (NCT02612857) [346]."

32203790

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Oligonucleotide inhibits TLR7. 1 / 1

INDRA sources:

Databases

Reading